Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T21:29:12.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2, replacing the prior v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T01:50:17.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-05T00:35:38.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A glossary feature was added to the page, and there are minor text/capitalization changes plus a new version label (Revision: v3.4.0). The core study content and user actions remain unchanged.
    Difference
    0.2%
    Check dated 2026-01-28T21:44:57.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T04:09:06.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section reorganized under a single Locations heading listing Florida and North Carolina; the HHS Vulnerability Disclosure link was removed and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:12:40.000Z thumbnail image

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.